Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach

Physiological Genomics

Volumn 2001, Issue 4, 2001, Pages 83-91

  Niculescu III, Alexander B ^a,b   Segal, David S ^a   Kuczenski, Ronald ^a   Barrett, Thomas ^a,b   Hauger, Richard L ^a,b   Kelsoe, John R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Amphetamine; Brain; GRK3; Microarrays

Indexed keywords

ARYL SULFOTRANSFERASE; CAENORHABDITIS ELEGANS PROTEIN; G PROTEIN COUPLED RECEPTOR KINASE 3; G-PROTEIN-COUPLED RECEPTOR KINASE 3; HELMINTH PROTEIN; LIN 7 PROTEIN, C ELEGANS; LIN 7 PROTEIN, MAMMALIAN; LIN-7 PROTEIN, C ELEGANS; LIN-7 PROTEIN, MAMMALIAN; LIN7A PROTEIN, HUMAN; LIN7C PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; OXIDOREDUCTASE; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN C; SQUALENE SYNTHASE; SULFOTRANSFERASE; SULT1A1 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BIPOLAR DISORDER; ENZYMOLOGY; GENETICS; GENOMICS; HUMAN; METABOLISM; METHODOLOGY; PSYCHOSIS; RAT; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ARYLSULFOTRANSFERASE; BIPOLAR DISORDER; CAENORHABDITIS ELEGANS PROTEINS; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; GENOMICS; HELMINTH PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; OXIDOREDUCTASES; PROTEIN-SERINE-THREONINE KINASES; PSYCHOTIC DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SULFOTRANSFERASES;

EID: 0347710163     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Andretic R, Chaney S, and Hirsh J. Requirement of circadian genes for cocaine sensitization in Drosophila. Science 285: 1066-1068, 1999.
2. Angrist B. Amphetamine psychosis: clinical variations of the syndrome. In: Amphetamine and Its Analogues, edited by Cho AK and Segal DS. San Diego: Academic, 1994, p. 387-414.
3. Arriza JL, Dawson TM, Simerly RB, Martin LJ, Caron MG, Snyder SH, and Lefkowitz RJ. The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain. J Neurosci 12: 4045-4055, 1992.
4. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, and Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14: 717-730, 1995.
5. Berrettini WH. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 47: 245-251, 2000.
6. Bina M, Demmon S, and Pares-Matos EI. Syndromes associated with Homo sapiens pol II regulatory genes. Prog Nucleic Acid Res Mol Biol 64: 171-219, 2000.
7. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, and Pulver AE. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20: 70-73, 1998.
8. Bunney WE and Bunney BG. Molecular clock genes in man and lower animals possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22: 335-345, 2000.
9. Butz S, Okamoto M, and Sudhof TC. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell 94: 773-782, 1998.
10. Dawson E, Parfitt E, Roberts Q, Daniels J, Lim L, Sham P, Nothen M, Propping P, Lanczik M, Maier W, Reuner U, Weissenbach J, Gill M, Powell J, McGuffin P, Owen M, and Craddock N. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. Am J Med Genet 60: 94-102, 1995.
11. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR, Karkera JD, Esterling LE, Zeng J, Ferraro TN, Guroff JJ, Kazuba D, Maxwell ME, Nurnberger JI Jr, and Gershon ES. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p112. Proc Natl Acad Sci USA 96: 5604-5609, 1999.
12. Detera-Wadleigh SD, Badner JA, Yoshikawa T, Sanders AR, Goldin LR, Turner G, Rollins DY, Moses T, Guroff JJ, Kazuba D, Maxwell ME, Edenberg HJ, Foroud T, Lahiri D, Nurnberger JIJ, Stine OC, McMahon F, Meyers DA, MacKinnon D, Simpson S, McInnis M, DePaulo JR, Rice J, Goate A, and Gershon ES. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet 74: 254-262, 1997.
13. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, and Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827, 1997.
14. Drummond SP, Brown GG, Gillin JC, Stricker JL, Wong EC, and Buxton RB. Altered brain response to verbal learning following sleep deprivation. Nature 403: 655-657, 2000.
15. Edenberg HJ, Foroud T, Conneally PM, Sorbel JJ, Carr K, Crose C, Willig C, Zhao J, Miller M, Bowman E, Mayeda A, Rau NL, Smiley C, Rice JP, Goate A, Reich T, Stine OC, McMahon F, DePaulo JR, Meyers D, Detera-Wadleigh SD, Goldin LR, Gershon ES, Blehar MC, and Nurnberger JIJ. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet 74: 238-246, 1997.
16. Engelberg H. Low serum cholesterol and suicide. Lancet 339: 727-729, 1992.
17. Ewald H, Mors O, Flint T, Koed K, Eiberg H, and Kruse TA. A possible locus for manic depressive illness on chromosome 16p13. Psychiatr Genet 5: 71-81, 1995.
18. Fibiger HC. The dopamine hypothesis of schizophrenia and mood disorders: contradictions and speculations. In: The Mesolimbic Dopamine System: From Motivation to Action, edited by Willner P and Scheel-Kruger J. Chichester: Wiley, 1991, p. 615-637.
19. Flores C, Rodaros D, and Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J Neurosci 18: 9547-9555, 1998.
20. Foroud T, Bucholz KK, Edenberg HJ, Goate A, Neuman RJ, Porjesz B, Koller DL, Rice J, Reich T, Bierut LJ, Cloninger CR, Nurnberger JI Jr, Li TK, Conneally PM, Tischfield JA, Crowe R, Hesselbrock V, Schuckit M, and Begleiter H. Linkage of an alcoholism-related severity phenotype to chromosome 16. Alcohol Clin Exp Res 22: 2035-2042, 1998.
21. Franken P, Lopez-Molina L, Marcacci L, Schibler U, and Tafti M. The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J Neurosci 20: 617-625, 2000.
22. Garcaia-Sevilla JA, Escribaa PV, Ozaita A, La Harpe R, Walzer C, Eytan A, and Guimaon J. Up-regulation of immunolabeled α2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 72: 282-291, 1999.
23. Hauger RL, Smith RD, Braun S, Dautzenberg FM, and Catt KJ. Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. Biochem Biophys Res Commun 268: 572-576, 2000.
24. Heimer L and Alheid GF. Piecing together the puzzle of basal forebrain anatomy. Adv Exp Med Biol 295: 1-42, 1991.
25. Hwang O and Choi HJ. Induction of gene expression of the catecholamine-synthesizing enzymes by insulin-like growth factor-I. J Neurochem 65: 1988-1996, 1995.
26. Jo K, Derin R, Li M, and Bredt DS. Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex. J Neurosci 19: 4189-4199, 1999.
27. Kandil E, Egashira M, Miyoshi O, Niikawa N, Ishibashi T, Kasahara M, and Miyosi O. The human gene encoding the heavy chain of the major histocompatibility complex class I-like Fc receptor (FCGRT) maps to 19q13.3. Cytogenet Cell Genet 73: 97-98, 1996.
28. Kaplan JR, Muldoon MF, Manuck SB, and Mann JJ. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann NY Acad Sci 836: 57-80, 1997.
29. Kato K, Katoh-Semba R, Takeuchi IK, Ito H, and Kamei K. Responses of heat shock proteins hsp27, αB-crystallin, and hsp70 in rat brain after kainic acid-induced seizure activity. J Neurochem 73: 229-236, 1999.
30. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, Harkavy FJ, Hampe C, Lee H, Shore D, Wynne D, Faraone SV, Tsuang MT, and Cloninger CR. NIMH Genetics Initiative Millennium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 81: 282-289, 1998.
31. Kelsoe JR. Recent progress in the search for genes for bipolar disorder. Curr Psychiat Rep 1: 135-140, 1999.
32. Kelsoe JR, Loetscher E, Spence MA, Foguet M, Sadovnick AD, Remick RA, Flodman P, Masser D, Ungerleider S, Rapaport MH, Wishart WL, and Luebbert H. A genome survey of bipolar disorder indicates a susceptibility locus on chromosome 22. Am J Med Genet 81: 461-462. 1998.
33. Kelsoe JR, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan MD, Rapaport MH, Flodman P, Spence MA, and Remick RA. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 67: 533-540, 1996.
34. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Easter SM, Webb BT, Zhang J, Walsh D, and Straub RE. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 153: 1534-1540, 1996.
35. Knusel B and Hefti F. Trophic actions of IGF-I, IGF-II and insulin on cholinergic and dopaminergic brain neurons. Adv Exp Med Biol 293: 351-360, 1991.
36. Koob GF. The role of the striatopallidal and extended amygdala systems in drug addiction. In: Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse, edited by McGinty JF. New York: NY Acad Sci, 1999, p. 445-460.
37. Kripke DF, Mullaney DJ, Atkinson M, and Wolf S. Circadian rhythm disorders in manic-depressives. Biol Psychiatry 13: 335-351, 1978.
38. Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, Pazur BA, Roe AA, Saito T, and Papolos DF. Linkage studies support a possible locus for bipolar disorder in the velocardiofacial syndrome region on chromosome 22. Am J Med Genet 74: 121-128, 1996.
39. Lander E and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247, 1995.
40. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, Hayward NK, Crowe RR, Andreasen NC, Black DW, Silverman JM, Endicott J, Sharpe L, Mohs RC, Siever LJ, Walters MK, Lennon DP, Jones HL, Nertney DA, Daly MJ, Gladis M, and Mowry BJ. Genome scan of schizophrenia. Am J Psychiatry 155: 741-750, 1998.
41. Lewis SE, Mannion RJ, White FA, Coggeshall RE, Beggs S, Costigan M, Martin JL, Dillmann WH, and Woolf CJ. A role for HSP27 in sensory neuron survival. J Neurosci 19: 8945-8953, 1999.
42. Michikawa M and Yanagisawa K. Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. Mech Ageing Dev 107: 233-243, 1999.
43. Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B, Laprise C, Bouchard G, Plante M, Gobeil L, Shink E, Weissenbach J, and Barden N. Genomewide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogenous population in Quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 88: 567-587, 1999.
44. Myles-Worsley M, Coon H, McDowell JE, Brenner C, Hoff M, Lind B, Rosenthal J, Bennett P, Freedman R, Clementz BA, and Byerley W. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet 88: 544-550, 1999.
45. Paxinos G and Watson C. The rat brain in stereotaxic coordinates. New York: Academic, 1997.
46. Pitcher JA, Freedman NJ, and Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem 67: 653-692, 1998.
47. Rabinovsky ED, Ramchatesingh J, and McManaman JL. Regulation of tyrosine hydroxylase gene expression in IMR-32 neuroblastoma cells by basic fibroblast growth factor and ciliary neurotrophic factor. J Neurochem 64: 2404-2412, 1995.
48. Ripperger JA, Shearman LP, Reppert SM, and Schibler U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev 14: 679-689, 2000.
49. Schechter I, Conrad DG, Hart I, Berger RC, McKenzie TL, Bleskan J, and Patterson D. Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1. Genomics 20: 116-118, 1994.
50. Schmidt EE and Schibler U. Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. J Cell Biol 128: 467-483, 1995.
51. Segal DS and Kuczenski R. Tyrosine hydroxylase activity: regional and subcellular distribution in the brain. Brain Res 68: 261-266, 1974.
52. Shilling PD, Kelsoe JR, Kuczenski R, and Segal DS. Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis. Neuroscience 96: 83-90, 2000.
53. Tiberi M, Nash SR, Bertrand L, Lefkowitz RJ, and Caron MG. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem 271: 3771-3778, 1996.
54. Tozawa R, Ishibashi S, Osuga J, Yagyu H, Oka T, Chen Z, Ohashi K, Perrey S, Shionoiri F, Yahagi N, Harada K, Gotoda T, Yazaki Y, and Yamada N. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 274: 30843-30848, 1999.
55. Wetterberg L, Peltonen L, Moises HW, Kidd KK, Sjogren B, Ekelund J, Jhala G, Neubauer B, Yang L, Sirugo G, and Pakstis AJ. Search for schizophrenia loci in a Swedish geographic isolate (Abstract). Am J Med Genet 81: 470, 1998.
56. Wilner P. Dopaminergic mechanisms in depression and mania. In: Psychopharmacology: The Fourth Generation of Progress, edited by Bloom FE and Kupfer DJ. New York: Raven, 1995, p. 921-931.
57. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE Jr, Fallon JH, and Keator D. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156: 1149-1158, 1999.
58. Yan L, Miyake S, and Okamura H. Distribution and circadian expression of dbp in SCN and extra-SCN areas in the mouse brain. J Neurosci Res 59: 291-295, 2000.